opens new tab have settled Acuitas' lawsuit demanding credit for inventions related to COVID-19 vaccines, according to a filing on Thursday in Virginia federal court. Acuitas sued CureVac last ...

CureVac and Acuitas Therapeutics have settled their COVID-19 vaccine dispute. According to a filing, submitted April 25, 2024 ...

In November 2023, Acuitas Therapeutics filed a lawsuit in Virginia federal court against CureVac, accusing it of failing to credit Acuitas on patents related to COVID-19 vaccines. Acuitas told the ...

Shares of Mullen Automotive (NASDAQ:MULN) stock are in the spotlight after the electric vehicle (EV) company announced that it had entered into a letter of agreement (LOA) with Acuitas Capital in ...

Beyond a doubt, Vancouver-based Acuitas Therapeutics, Inc. punches above its weight. It is the global leader in developing lipid nanoparticle (LNP) delivery technology for nucleic acid ...

(Brittain, 4/25) Reuters: Acuitas, CureVac Settle Lawsuit Over COVID-19 Vaccine Patent Rights Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit demanding ...

Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for ...

On October 31, 2023, the Company and Acuitas Capital entered into a Fifth Amendment to the Master Note Purchase Agreement, as amended (the "Fifth Amendment"), which, among other things ...

Benzinga - by Vandana Singh, Benzinga Editor. Canadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV (NASDAQ:CVAC) have settled Acuitas’ lawsuit over credit for inventions tied to ...